Philippe Y. Delannoy
Villeneuve-d'ascq, 59655, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Anti-OAcGD2 antibody in combination with ceramide kinase inhibitor mediates potent antitumor cytotoxicity against breast cancer and diffuse intrinsic pontine glioma cells.
Journal: Molecular and cellular biochemistry
Published: April 10, 2024
Reticular and Golgi glycosylation: Advances and associated diseases
Journal: Medecine sciences : M/S
Published: June 28, 2021
Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy.
Journal: International journal of molecular sciences
Published: April 29, 2021
Role of Sialyl-O-Acetyltransferase CASD1 on GD2 Ganglioside O-Acetylation in Breast Cancer Cells.
Journal: Cells
Published: April 12, 2021
O-acetylated Gangliosides as Targets for Cancer Immunotherapy.
Journal: Cells
Published: February 27, 2020
Glycosylation changes in inflammatory diseases.
Journal: Advances in protein chemistry and structural biology
Published: January 31, 2020
Profiling of O-acetylated Gangliosides Expressed in Neuroectoderm Derived Cells.
Journal: International journal of molecular sciences
Published: November 22, 2019
Gangliosides: The Double-Edge Sword of Neuro-Ectodermal Derived Tumors.
Journal: Biomolecules
Published: June 25, 2019
Novel Zebrafish Mono-α2,8-sialyltransferase (ST8Sia VIII): An Evolutionary Perspective of α2,8-Sialylation.
Journal: International journal of molecular sciences
Published: December 18, 2018
Identification of 9-O-acetyl-N-acetylneuraminic acid (Neu5,9Ac2) as main O-acetylated sialic acid species of GD2 in breast cancer cells.
Journal: Glycoconjugate journal
Published: September 04, 2018
Gangliosides in Cancer Cell Signaling.
Journal: Progress in molecular biology and translational science
Published: May 12, 2018
Last Updated: 09/26/2026